KPIs & Operating Metrics(New)
Cash Flow Statement
Growth Metrics

Bausch Health Companies (BHC) Cash from Financing Activities (2016 - 2026)

Bausch Health Companies' Cash from Financing Activities history spans 18 years, with the latest figure at -$100.0 million for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 31.51% to -$100.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$696.0 million, a 3.26% decrease, with the full-year FY2025 number at -$742.0 million, up 14.52% from a year prior.
  • Cash from Financing Activities hit -$100.0 million in Q1 2026 for Bausch Health Companies, up from -$235.0 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for BHC hit a ceiling of $1.8 billion in Q3 2023 and a floor of -$719.0 million in Q3 2025.
  • Historically, Cash from Financing Activities has averaged -$41.7 million across 5 years, with a median of -$142.0 million in 2023.
  • Biggest five-year swings in Cash from Financing Activities: surged 5144.44% in 2023 and later tumbled 376.47% in 2025.
  • Tracing BHC's Cash from Financing Activities over 5 years: stood at -$276.0 million in 2022, then soared by 71.38% to -$79.0 million in 2023, then skyrocketed by 207.59% to $85.0 million in 2024, then tumbled by 376.47% to -$235.0 million in 2025, then skyrocketed by 57.45% to -$100.0 million in 2026.
  • Business Quant data shows Cash from Financing Activities for BHC at -$100.0 million in Q1 2026, -$235.0 million in Q4 2025, and -$719.0 million in Q3 2025.